Integral Diagnostics Limited (ASX:IDX)

Market Cap	1.05B
Revenue (ttm)	627.22M
Net Income (ttm)	4.67M
Shares Out	372.41M
EPS (ttm)	0.02
PE Ratio	186.55
Forward PE	21.26
Dividend	0.07 (2.31%)
Ex-Dividend Date	Aug 29, 2025

Volume	636,794
Average Volume	874,927
Open	2.830
Previous Close	2.850
Day's Range	2.780 - 2.830
52-Week Range	1.910 - 3.200
Beta	0.17
RSI	46.12
Earnings Date	Nov 25, 2025

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX